Trial Profile
Randomized, controlled study of Selegiline in enhancing cognitive and functional recovery in stroke survivors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Selegiline (Primary)
- Indications Stroke; Stroke complications
- Focus Pharmacodynamics; Therapeutic Use
- 28 Oct 2015 New trial record